CONCLUSION
While rates of adverse neonatal outcomes were similar in index and subsequent GDM pregnancies, the risk was greatly increased in women who had an adverse outcome in the first pregnancy. This is despite decreased rates of adverse delivery outcomes. Our study identifies a group of women with recurrent GDM and previous LGA, who may stand to gain the most from intensive management of their glucose levels and weight. It also discerns a group of women with recurrent GDM and previous SGA in whom intensive or early therapy might potentially be unwarranted, given the high risk of recurrent SGA and the low risk of LGA.